Gerald D. Cagle - Net Worth and Insider Trading
Gerald D. Cagle Net Worth
The estimated net worth of Gerald D. Cagle is at least $301,332 dollars as of 2024-09-18. Gerald D. Cagle is the Director of Aerie Pharmaceuticals Inc and owns about 16,550 shares of Aerie Pharmaceuticals Inc (AERI) stock worth over $252,388. Gerald D. Cagle is also the Director of Clearside Biomedical Inc and owns about 37,505 shares of Clearside Biomedical Inc (CLSD) stock worth over $48,944. Details can be seen in Gerald D. Cagle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gerald D. Cagle has not made any transactions after 2020-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gerald D. Cagle
Gerald D. Cagle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gerald D. Cagle owns 3 companies in total, including CalciMedica Inc (CALC) , Aerie Pharmaceuticals Inc (AERI) , and Clearside Biomedical Inc (CLSD) .
Click here to see the complete history of Gerald D. Cagle’s form 4 insider trades.
Insider Ownership Summary of Gerald D. Cagle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CALC | CalciMedica Inc | 2020-09-24 | director |
AERI | Aerie Pharmaceuticals Inc | 2020-05-08 | director |
CLSD | Clearside Biomedical Inc | 2018-03-22 | director |
Gerald D. Cagle Latest Holdings Summary
Gerald D. Cagle currently owns a total of 2 stocks. Among these stocks, Gerald D. Cagle owns 16,550 shares of Aerie Pharmaceuticals Inc (AERI) as of May 8, 2020, with a value of $252,388 and a weighting of 83.76%. Gerald D. Cagle also owns 37,505 shares of Clearside Biomedical Inc (CLSD) as of March 22, 2018, with a value of $48,944 and a weighting of 16.24%.
Latest Holdings of Gerald D. Cagle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AERI | Aerie Pharmaceuticals Inc | 2020-05-08 | 16,550 | 15.25 | 252,388 |
CLSD | Clearside Biomedical Inc | 2018-03-22 | 37,505 | 1.31 | 48,944 |
Holding Weightings of Gerald D. Cagle
Gerald D. Cagle Form 4 Trading Tracker
According to the SEC Form 4 filings, Gerald D. Cagle has made a total of 1 transactions in Aerie Pharmaceuticals Inc (AERI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Aerie Pharmaceuticals Inc is the sale of 5,000 shares on May 8, 2020, which brought Gerald D. Cagle around $76,350.
According to the SEC Form 4 filings, Gerald D. Cagle has made a total of 0 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years. The most-recent trade in Clearside Biomedical Inc is the acquisition of 7,500 shares on March 22, 2018, which cost Gerald D. Cagle around $89,175.
Insider Trading History of Gerald D. Cagle
- 1
Gerald D. Cagle Trading Performance
GuruFocus tracks the stock performance after each of Gerald D. Cagle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald D. Cagle is 19.56%. GuruFocus also compares Gerald D. Cagle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald D. Cagle within 3 months outperforms 7 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gerald D. Cagle's insider trading performs compared to the benchmark.
Performance of Gerald D. Cagle
Gerald D. Cagle Ownership Network
Gerald D. Cagle Owned Company Details
What does CalciMedica Inc do?
Who are the key executives at CalciMedica Inc?
Gerald D. Cagle is the director of CalciMedica Inc. Other key executives at CalciMedica Inc include director & 10 percent owner & Chief Executive Officer A. Rachel Leheny , director & 10 percent owner & Chief Business Officer Eric W Roberts , and 10 percent owner Sanderling Venture Partners Vi Co Investment Fund Lp .
CalciMedica Inc (CALC) Insider Trades Summary
Over the past 18 months, Gerald D. Cagle made no insider transaction in CalciMedica Inc (CALC). Other recent insider transactions involving CalciMedica Inc (CALC) include a net purchase of 80,404 shares made by Eric W Roberts , a net purchase of 21,768 shares made by A. Rachel Leheny , and a net purchase of 691,098 shares made by Fred A Middleton .
In summary, during the past 3 months, insiders sold 0 shares of CalciMedica Inc (CALC) in total and bought 129,721 shares, with a net purchase of 129,721 shares. During the past 18 months, 0 shares of CalciMedica Inc (CALC) were sold and 1,635,136 shares were bought by its insiders, resulting in a net purchase of 1,635,136 shares.
CalciMedica Inc (CALC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CalciMedica Inc Insider Transactions
Gerald D. Cagle Mailing Address
Above is the net worth, insider trading, and ownership report for Gerald D. Cagle. You might contact Gerald D. Cagle via mailing address: 135 U.s. Highway 206, Suite 15, Bedminster Nj 07921.